The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Amicus Therapeutics Inc. Common 03152W109   4,889,006 400,410 SH   SOLE   400,410 0 0
Arcutis Biotherapeutics inc Common 03969K108   3,878,621 262,069 SH   SOLE   262,069 0 0
AVROBIO, Inc. Common 05455M100   461,901 647,918 SH   SOLE   647,918 0 0
Axsome Therapeutics, Inc. Common 05464T104   4,008,832 51,975 SH   SOLE   51,975 0 0
Black Diamond Therapeutics, Inc. Common 09203E105   260,798 144,888 SH   SOLE   144,888 0 0
Chinook Therapeutics, Inc. Common 16961L106   2,096,000 80,000 SH   SOLE   80,000 0 0
Crinetics Pharmaceuticals Inc. Common 22663K107   6,800,994 371,639 SH   SOLE   371,639 0 0
Cullinan Oncology, Inc. Common 230031106   80,689,227 7,648,268 SH   SOLE   7,648,268 0 0
G1 Therapeutics, Inc. Common 3621LQ109   3,529,500 650,000 SH   SOLE   650,000 0 0
Geron Corporation Common 374163103   20,490,094 8,466,981 SH   SOLE   8,466,981 0 0
Harmony Biosciences Hldgs Inc. Common 413197104   7,679,673 139,377 SH   SOLE   139,377 0 0
Harpoon Therapeutics, Inc. Common 41358P106   2,320,809 3,196,707 SH   SOLE   3,196,707 0 0
Inhibrx, Inc Com Common 45720L107   31,697,758 1,286,435 SH   SOLE   1,286,435 0 0
Inozyme Pharma Inc. Common 45790W108   242,025 230,500 SH   SOLE   230,500 0 0
Insmed Incorporated Common 457669307   8,201,051 410,463 SH   SOLE   410,463 0 0
Intellia Therapeutics, Inc. Common 45826J105   15,883,254 455,238 SH   SOLE   455,238 0 0
Iovance Biotherapeutics Inc Com Common 462260100   13,735,625 2,149,550 SH   SOLE   2,149,550 0 0
iTeos Therapeutics, Inc. Common 46565G104   34,098,267 1,745,943 SH   SOLE   1,745,943 0 0
Iveric Bio Inc Common 46583P102   22,687,920 1,059,688 SH   SOLE   1,059,688 0 0
Madrigal Pharmaceuticals inc Common 558868105   7,770,863 26,773 SH   SOLE   26,773 0 0
Oncorus, Inc. Common 68236R103   601,389 2,377,031 SH   SOLE   2,377,031 0 0
Phathom Pharmaceuticals inc Common 71722W107   2,198,469 195,942 SH   SOLE   195,942 0 0
Praxis Precision Medicines Inc. Common 74006W108   1,451,800 610,000 SH   SOLE   610,000 0 0
Provention Bio Inc Common 74374N102   9,496,965 898,483 SH   SOLE   898,483 0 0
Reata Pharmaceuticals inc-a Common 75615P103   7,376,936 194,181 SH   SOLE   194,181 0 0
REGENXBIO Inc. Common 75901B107   14,092,717 621,372 SH   SOLE   621,372 0 0
Repare Therapeutics, Inc. Common 760273102   24,122,179 1,639,849 SH   SOLE   1,639,849 0 0
Revolution Medicines, Inc. Common 76155X100   3,550,204 149,043 SH   SOLE   149,043 0 0
TCR2 Therapeutics, Inc. Common 87808K106   3,367,611 3,370,982 SH   SOLE   3,370,982 0 0
Travere Therapeutics Inc. Common 89422G107   5,924,382 281,711 SH   SOLE   281,711 0 0
Uniqure N.V. Common N90064101   21,309,029 939,966 SH   SOLE   939,966 0 0
Verve Therapeutics, Inc Common 92539P101   15,647,590 808,661 SH   SOLE   808,661 0 0
Werewolf Therapeutics, Inc. Common 95075A107   4,895,423 2,388,011 SH   SOLE   2,388,011 0 0